Cargando…
Development of donepezil-induced hypokalemia following treatment of cognitive impairment
Donepezil is a cholinesterase inhibitor used extensively to treat Alzheimer disease. The increased cholinergic activity is associated with adverse effects, therefore gastrointestinal symptoms, including nausea, vomiting, and diarrhea, are common. Hypokalemia is a rare adverse event that occurs in le...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Yeungnam University College of Medicine
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787899/ https://www.ncbi.nlm.nih.gov/pubmed/33045804 http://dx.doi.org/10.12701/yujm.2020.00269 |